Trial · NCT00187278
Registered outcomes17
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 17 of 17
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Total Mortality | Study duration (5.7 years mean follow-up) | Number of deaths observed |
| Primary | Death or Heart Failure Hospitalization | Study duration (5.7 years mean follow-up) | Number of subjects who experienced death or hospitalization where heart failure is a primary cause of hospitalization |
| Secondary | Death Due to Cardiovascular Causes | Study duration (5.7 years mean follow-up) | Number of subjects who died due to cardiovascular causes, as classified by the independent Event Adjudication Committee (IEAC) |
| Secondary | Functional Capacity as Measured by the Distance Covered in the 6-minute Walk Test | 12 months post-implant | |
| Secondary | Health Related Quality of Life Measured by the Minnesota Living With Heart Failure Questionnaire© | 12 months post-implant | Minnesota Living with Heart Failure (MLWHF) questionnaire score at 12 months MLWHF score: the total scale is from 0 to 105, with higher scores indicating worse health status. |
| Secondary | Incidence of Hospitalizations for Deterioration of Heart Failure | Study duration (5.7 years mean follow-up) | |
| Secondary | Incidence of Hospitalizations for Cardiovascular Events | Study duration (5.7 years mean follow-up) | |
| Secondary | Incidence of Hospitalizations for Any Reason | Study duration (5.7 years mean follow-up) | |
| Secondary | Cardiac Structure and Function | 12 & 24 months | |
| Secondary | Successful Implantation of the Left Ventricular Lead | Implantation | |
| Secondary | Chronic Atrial Fibrillation (Defined as Presence of Atrial Fibrillation in Two Subsequent ECG´s/Visits) | Study duration (5.7 years mean follow-up) | Chronic atrial fibrillation is defined as presence of atrial fibrillation in two subsequent ECG´s/visits. |
| Secondary | Functional Capacity as Measured by the Distance Covered in the 6-minute Walk Test | 24 months post-implant | |
| Secondary | Health Related Quality of Life Measured by the Minnesota Living With Heart Failure Questionnaire© | 24 months post-implant | Minnesota Living with Heart Failure (MLWHF) questionnaire score at 24 months. MLWHF score: the total scale is from 0 to 105, with higher scores indicating worse health status. |
| Secondary | Duration of Hospitalizations for Deterioration of Heart Failure | Study Duration (5.7 years mean follow-up) | |
| Secondary | Duration of Hospitalizations for Cardiovascular Events | Study Duration (5.7 years mean follow-up) | |
| Secondary | Duration of Hospitalizations for Any Reason | Study duration (5.7 years mean follow-up) | |
| Secondary | Adverse Events Related to Left Ventricular Lead | Study Duration (5.7 years mean follow-up) | Only serious adverse events related to the left ventricular lead are included. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00187278/registered